US pharma giant Pfizer (NYSE: PFE) has launched an initiative that it calls ‘An Accord for a Healthier World’.
The company, which has seen its sales and profits spiral since the COVID-19 pandemic, aims to provide all of Pfizer’s patented, high-quality medicines and vaccines available in the USA or the European Union on a not-for-profit basis to 1.2 billion people in 45 lower-income countries.
"As we learned in the global COVID-19 vaccine roll-out, supply is only the first step to helping patients"With this initiative, Pfizer says that it wants to ‘greatly reduce the health inequities that exist between many lower-income countries and the rest of the world’.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze